FREMONT, Calif. (AP) -- PDL BioPharma Inc. said Chief Executive Mark McDade will resign by the end of 2007 and that an internal investigation found no credible evidence of improper personal conduct or breach of fiduciary duty.
FREMONT, Calif. (AP) -- PDL BioPharma Inc. said Chief Executive Mark McDade will resign by the end of 2007 and that an internal investigation found no credible evidence of improper personal conduct or breach of fiduciary duty.
